Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Headache and raised intracranial pressure

Palliative and end-of-life care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Impending cerebral herniation

Rapidly falling consciousness, new fixed or unequal pupils, extensor posturing, bradycardia with hypertension, seizure or acute focal deficit may indicate critical intracranial pressure or haemorrhage.

Action: Call emergency neurological and critical-care help within the treatment ceiling, use ABCDE care, elevate the head about 30 degrees with neutral neck, correct hypoxia and glucose and obtain urgent CT. Give dexamethasone promptly for suspected tumour-related oedema and use hyperosmolar therapy only under the acute specialist protocol while definitive surgery or radiotherapy is decided.

Synopsis

Recognise headache patterns that indicate intracranial mass effect or another neurological emergency, image before unsafe lumbar puncture, relieve tumour oedema with proportionate corticosteroid and coordinate neurosurgical, radiotherapy and comfort decisions.

  • Ask about onset speed, progression, morning or positional pattern, cough or strain, vomiting, seizure, cognition, focal symptoms and analgesic or steroid exposure.
  • First-line examination records consciousness, pupils, cranial nerves, power, sensation, coordination, gait, fundoscopy when feasible and vital signs.
  • Urgent non-contrast CT is first-line for acute haemorrhage, major mass effect and hydrocephalus; contrast MRI is the gold-standard definition of brain tumour and metastatic burden after stabilisation.
  • Never perform lumbar puncture before excluding unsafe raised intracranial pressure when papilloedema, focal deficit, seizure or altered consciousness is present.
  • For symptomatic tumour-related oedema, dexamethasone commonly starts at 4 to 8 mg daily for moderate symptoms and up to 16 mg daily for severe pressure features under specialist guidance.
  • Give dexamethasone early in the day where possible, monitor glucose and mental state and use the lowest effective dose with a written taper linked to surgery or radiotherapy.
  • Definitive treatment may be neurosurgical resection, cerebrospinal-fluid diversion, stereotactic treatment, whole-brain radiotherapy or systemic therapy according to tumour, function and goals.
  • Do not start antiseizure medication solely as prophylaxis in every seizure-naive brain-tumour patient; treat an actual seizure through the neurological pathway.
  • The gold-standard plan connects imaging, steroid goal and taper, definitive treatment, seizure rescue, analgesia and escalation ceiling while preserving comfort if intervention is declined.

Key red flags

Thunderclap onset, meningism, fever, collapse or new neurological deficit requires immediate haemorrhage, infection and vascular assessment.

Progressive morning or positional headache with vomiting, papilloedema, focal signs or cognitive change suggests raised intracranial pressure.

Reduced consciousness, unequal pupils, extensor response or Cushing physiology is a late herniation sign and requires emergency action.

Do not perform lumbar puncture when mass lesion, obstructive hydrocephalus, papilloedema or focal deficit raises herniation risk.

New seizure or persistent postictal deficit requires urgent glucose, imaging and seizure management rather than analgesia alone.

Dexamethasone can cause severe hyperglycaemia, infection, psychosis, insomnia, gastrointestinal harm and proximal weakness and needs the lowest effective dose and taper plan.

NSAIDs and contrast require renal and bleeding review, while valproate and many sedatives require hepatic caution.

Impending herniation

Rapid coma, unequal pupils, extensor posturing or Cushing physiology requires immediate emergency neurological management.

Investigation priorities

01
First-line serial neurological examinationFirst stepFirst line

Document arousal, pupils, cranial nerves, fields, speech, limbs, coordination, gait and fundoscopy to identify change and localisation.

Management branches

Emergency pressureStabilise and image before deterioration

Headache accompanies falling consciousness, new pupil change, focal deficit, repeated vomiting, seizure or late pressure signs.

  1. Call neurological and critical-care help, use ABCDE care, elevate the head about 30 degrees, maintain neutral neck and correct hypoxia, hypotension and glucose disturbance.
  2. Obtain urgent non-contrast CT and give dexamethasone promptly for suspected tumour oedema; use hyperosmolar treatment only through the acute specialist protocol.
  3. Coordinate neurosurgery, cerebrospinal-fluid diversion, radiotherapy or comfort-focused care based on pathology, reversibility, capacity and the documented treatment ceiling.

Key medicines

Dexamethasone for tumour-related cerebral oedemaUse 4 to 8 mg orally or intravenously daily for moderate symptomatic tumour oedema and up to 16 mg daily for severe pressure symptoms under the local neuro-oncology protocol, usually given once or in earlier divided doses with a documented taper.Monitor glucose, infection, mood, psychosis, insomnia, proximal weakness, gastrointestinal risk and adrenal suppression; use the lowest effective dose and avoid abrupt cessation after sustained therapy.
Paracetamol for headacheFor an adult at least 50 kg without liver-risk factors, give 500 mg to 1 g orally every 4 to 6 hours as required, maximum 4 g in 24 hours; reduce the maximum for low weight, malnutrition, alcohol excess or hepatic disease.Reconcile combination products and all routes and do not allow symptomatic relief to delay imaging for red flags or pressure deterioration.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG99 brain tumours and metastasesImaging, surgery, radiotherapy, corticosteroid and seizure prophylaxis recommendations.
  • UKONS acute oncology guidelinesEmergency assessment of raised intracranial pressure and brain metastasis complications.
  • BNF dexamethasone monographDosing, adverse effects, interactions, adrenal suppression and taper safety.
  • RCR radiotherapy dose fractionationRadiotherapy approaches for brain metastases and palliative neurological symptoms.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom